Sign inJoin waitlistJoin the waitlist

MK

Matthew Klairmont

Credentials: ·

History

Hematopathology
NYU Grossman School of Medicine
2020–2021
Pathology
University of Tennessee College of Medicine
2014–2018
Rush Medical College of Rush University Medical Center
2010–2014

Research

Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma
Review · Cancer Biology & Therapy · 2021 · 30 citations
The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma
Cancer immunology · 2015 · 26 citations
Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia
Modern Pathology · 2021 · First of 9 authors · 13 citations

JG
Joel Gradowski
5 papers
JC
John Choi
5 papers · 2 as a fellow
JC
Jinjun Cheng
4 papers · 4 as a resident
ML
Minh Luu
3 papers
SD
Shaun Daly
3 papers · 3 as a resident
Ching-Hon Pui
2 papers
DD
Daniel Deziel
2 papers
Hiroto Inaba
2 papers
HK
Howard Kaufman
2 papers
Tasha Hughes
2 papers · 1 as a resident
Ania Owczarczyk
1 paper · 1 as a fellow
AH
Ashley Holland
1 paper